GKIM
FOLD

GW&K Investment Management’s Amicus Therapeutics FOLD Stock Holding History

GW&K Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-485
Closed -$5K – 390
2021
Q2 		$5K Hold
485
– – ﹤0.01% 391
2021
Q1 		$5K Sell
485
-432,318
-100% -$6.69M ﹤0.01% 374
2020
Q4 		$9.99M Sell
432,803
-8,906
-2% -$182K 0.1% 219
2020
Q3 		$6.24M Sell
441,709
-8,667
-2% -$126K 0.08% 230
2020
Q2 		$6.79M Sell
450,376
-101,125
-18% -$1.23M 0.1% 222
2020
Q1 		$5.1M Sell
551,501
-28,798
-5% -$274K 0.09% 213
2019
Q4 		$5.65M Sell
580,299
-31,979
-5% -$293K 0.08% 232
2019
Q3 		$4.91M Buy
612,278
+181,060
+42% +$1.97M 0.07% 241
2019
Q2 		$5.38M Sell
431,218
-4,471
-1% -$56.7K 0.08% 229
2019
Q1 		$5.92M Sell
435,689
-67,294
-13% -$822K 0.1% 216
2018
Q4 		$4.82M Sell
502,983
-5,150
-1% -$56.6K 0.1% 204
2018
Q3 		$6.14M Buy
508,133
+214,421
+73% +$3M 0.1% 203
2018
Q2 		$4.59M Sell
293,712
-3,179
-1% -$48.1K 0.08% 214
2018
Q1 		$4.46M Sell
296,891
-458
-0.2% -$6.97K 0.08% 214
2017
Q4 		$4.28M Buy
297,349
+22,289
+8% +$306K 0.07% 208
2017
Q3 		$4.15M Sell
275,060
-109,895
-29% -$1.45M 0.07% 196
2017
Q2 		$3.88M Sell
384,955
-12,070
-3% -$97.1K 0.07% 188
2017
Q1 		$2.83M Buy
397,025
+74
+0% +$468 0.05% 196
2016
Q4 		$1.97M Sell
396,951
-64,495
-14% -$446K 0.04% 208
2016
Q3 		$3.42M Sell
461,446
-7,262
-2% -$49.1K 0.06% 194
2016
Q2 		$2.56M Buy
468,708
+51,273
+12% +$359K 0.05% 200
2016
Q1 		$3.53M Buy
417,435
+193,560
+86% +$1.37M 0.08% 186
2015
Q4 		$2.17M Buy
223,875
+93,385
+72% +$842K 0.05% 185
2015
Q3 		$1.83M Sell
130,490
-62,745
-32% -$984K 0.04% 187
2015
Q2 		$2.73M Sell
193,235
-3,000
-2% -$36.1K 0.06% 178
2015
Q1 		$2.13M Buy
+196,235
New +$1.73M 0.05% 188

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GW&K Investment Management's FOLD Position: Q3 2021 in Review

GW&K Investment Management sold out of Amicus Therapeutics (FOLD) in Q3 2021, closing a stake of 485 shares — an estimated $5K sold.

GW&K Investment Management first reported a position in FOLD in Q1 2015 and held it in 26 quarters. The position peaked at $9.99M in Q4 2020. 237 funds tracked by Wall St. Rank hold FOLD as of Q3 2021.

  • GW&K Investment Management reported no remaining Amicus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • GW&K Investment Management sold 485 Amicus Therapeutics shares in Q3 2021, an estimated $5K.
  • GW&K Investment Management first reported a position in Amicus Therapeutics in Q1 2015 and held it in 26 quarters.
  • GW&K Investment Management's Amicus Therapeutics position peaked at $9.99M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2021.

Based on GW&K Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.